Growing Through Challenges? – Bristol-Myers Squibb Co. (BMY)
Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of -8.34% and -9.76% over the past three months. BMY shares are trading -12.59% year to date (YTD), with the 12-month market performance down to -34.06% lower. […]
Bristol-Myers Squibb Co. (BMY) Testing Investors’ Patience Right Now
Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of 1.35% and -2.35% over the past three months. BMY shares are trading -4.64% year to date (YTD), with the 12-month market performance down to -29.96% lower. […]
Growing Through Challenges? – Bristol-Myers Squibb Co. (BMY)
Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade. However, the script later moved the day high at 49.09, down -1.71%. The company’s stock has a 5-day price change of -5.92% and -3.86% over the past three months. BMY shares are trading -5.91% year […]
Growing Through Challenges? – Bristol-Myers Squibb Co. (BMY)
Currently, there are 2.02B common shares owned by the public and among those 2.02B shares have been available to trade. The company’s stock has a 5-day price change of -5.37% and -1.38% over the past three months. BMY shares are trading 0.02% year to date (YTD), with the 12-month market performance down to -25.53% lower. […]
Bristol-Myers Squibb Co. (BMY) Volatility Spurs A Quest For Clarity
Currently, there are 2.02B common shares owned by the public and among those 2.02B shares have been available to trade. The company’s stock has a 5-day price change of 5.12% and 5.90% over the past three months. BMY shares are trading 5.69% year to date (YTD), with the 12-month market performance down to -20.48% lower. […]
Bristol-Myers Squibb Co. (NYSE: BMY) Is Getting Increasingly Hard To Ignore
Currently, there are 2.02B common shares owned by the public and among those 2.02B shares have been available to trade. However, the script later moved the day high at 54.60, up 0.66%. The company’s stock has a 5-day price change of -0.78% and 1.90% over the past three months. BMY shares are trading 1.21% year […]
Bristol-Myers Squibb Co. (NYSE: BMY) Loses -26.35% From High. Why That Could Change?
Currently, there are 2.02B common shares owned by the public and among those 2.02B shares have been available to trade. The company’s stock has a 5-day price change of -2.70% and 0.93% over the past three months. BMY shares are trading 2.01% year to date (YTD), with the 12-month market performance down to -22.44% lower. […]
Gains May Be On The Menu For Bristol-Myers Squibb Co. (NYSE: BMY)
Currently, there are 2.02B common shares owned by the public and among those 2.02B shares have been available to trade. However, the script later moved the day high at 54.26, up 0.96%. The company’s stock has a 5-day price change of 5.70% and 7.84% over the past three months. BMY shares are trading 4.83% year […]
Value Hunters: Look To Bristol-Myers Squibb Co. (BMY)
Currently, there are 2.02B common shares owned by the public and among those 2.02B shares have been available to trade. Insiders at the company have transacted a total of 136 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 85 of these insider trades were purchases, […]
Bristol-Myers Squibb Co. (BMY): Street Finally Waking Up
Currently, there are 2.02B common shares owned by the public and among those 2.02B shares have been available to trade. Insiders at the company have transacted a total of 136 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 85 of these insider trades were purchases, […]
